Insider trading

Period: 12 months Role: Other officers × Minimum amount: $1M × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

4,650 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

4,650 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

4,650 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

4,650 decisions over 12 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
4,650 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
4,650 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

4,650 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
24 Nov 2025
Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER
Sold on a plan 5×
$2.85M 35,572 at 80.18
26.1%
Planned (10b5-1)
24 Nov 2025
KAO GEORGE SVP, OPERATIONS
Sold at will
$1.87M 56,904 at 32.83
29.7%
Not planned
24 Nov 2025
Klein Frank Chief Operations Officer
Sold at will 3×
$1.70M 41,782 at 40.65
3.2%
Not planned
24 Nov 2025
Watanabe Todd See Remarks
Sold on a plan
$1.49M 48,945 at 30.36
6.2%
Planned (10b5-1)
24 Nov 2025
Brock Lawrence J Chief People Officer
Sold on a plan 13×
$1.48M 5,902 at 250.58
92.2%
Sold half or more
24 Nov 2025
Moore Stephanie Zapata EVP and General Counsel
Sold at will
$1.42M 8,219 at 173.35
9.3%
Not planned
24 Nov 2025
Kurtzman Diane EVP & Chief HR Officer
Sold at will
$1.39M 4,805 at 290.00
55.7%
Sold half or more
24 Nov 2025
Lee Benjamin Seong Chief Legal Officer
Sold on a plan 8×
$1.24M 6,427 at 192.68
8.7%
Planned (10b5-1)
24 Nov 2025
Barrysmith Mark Chief Accounting Officer
Sold at will
$1.23M 29,599 at 41.41
6.5%
Not planned
24 Nov 2025
Kampani Arjun SVP General Counsel &
Sold at will 3×
$1.16M 28,615 at 40.65
5.8%
Not planned
24 Nov 2025
Gallagher Daniel Martin Jr Chief Legal Officer
Sold on a plan 6×
$1.13M 10,000 at 112.98
1.8%
Planned (10b5-1)
21 Nov 2025
Karp Alexander C. See Remarks
Sold at will 3×
$7.12M 45,564 at 156.25
0.7%
Not planned
21 Nov 2025
Cohen Stephen Andrew See Remarks
Sold at will 3×
$6.12M 39,136 at 156.25
98.5%
Sold half or more
21 Nov 2025
MURDOCH KEITH RUPERT Chairman Emeritus · indirect
Sold at will
$5.93M 100,000 at 59.26
8.3%
Not planned
21 Nov 2025
BENZENO SHARON Chief Commercial Ofc Imm Med
Sold on a plan
$5.22M 308,477 at 16.91
51.0%
Sold half or more
21 Nov 2025
Zatlyn Michelle President and Board Co-Chair · indirect
Sold on a plan 4×
$4.82M 25,641 at 188.13
51.1%
Sold half or more
21 Nov 2025
Gupta Suren President,Enterprise Solutions
Sold on a plan
$4.71M 21,871 at 215.21
17.9%
Planned (10b5-1)
21 Nov 2025
Schlitz Lei Zhang VP & Pres, Global Products
Sold at will
$3.63M 32,031 at 113.20
32.4%
Not planned
21 Nov 2025
Hao Xinyan Chief Operating Officer · indirect
Sold on a plan
$3.52M 100,000 at 35.18
19.7%
Planned (10b5-1)
21 Nov 2025
DOYLE J PATRICK Executive Chairman
Sold at will 3×
$3.04M 43,597 at 69.80
18.4%
Not planned
21 Nov 2025
Sankar Shyam See Remarks
Sold at will 3×
$2.97M 19,004 at 156.25
2.9%
Not planned
21 Nov 2025
Dimopoulos Christos Executive VP, Global Markets
Sold at will 2×
$2.39M 25,300 at 94.37
19.5%
Not planned
21 Nov 2025
Lampropoulos Fred P. Executive Chairman
Sold at will
$2.18M 25,000 at 87.31
2.4%
Not planned
21 Nov 2025
Stanton Marshall S. SVP, Clinical & MD Affair
Sold at will 4×
$2.13M 47,376 at 45.04
51.4%
Sold half or more
21 Nov 2025
Taneja Rajat PRESIDENT, TECHNOLOGY
Sold on a plan
$2.08M 6,305 at 330.00
2.6%
Planned (10b5-1)
21 Nov 2025
Zapolsky David Senior Vice President
Sold on a plan 5×
$1.54M 7,100 at 216.94
11.5%
Planned (10b5-1)
21 Nov 2025
Mansueto Joseph D Executive Chairman
Sold on a plan 5×
$1.53M 7,250 at 211.22
0.1%
Planned (10b5-1)
21 Nov 2025
Swieringa John PRES, TECH & COO
Sold at will
$1.48M 22,000 at 67.34
7.2%
Not planned
21 Nov 2025
Rowland David Donnay EVP & Co-Chief Invest. Officer
Sold at will
$1.45M 5,000 at 290.57
22.2%
Not planned
21 Nov 2025
GUSTAVSON JEFF B Vice President
Sold at will
$1.40M 9,325 at 150.27
84.8%
Sold half or more
21 Nov 2025
Madsen Julia Sr. VP and GM, Life Sciences
Sold at will 2×
$1.31M 5,008 at 262.00
31.9%
Not planned
21 Nov 2025
Haley Patrick J. EVP, Commercial
Sold at will
$1.19M 28,043 at 42.58
7.0%
Not planned
21 Nov 2025
Pinto Arun Chief Risk Officer
Sold on a plan
$1.14M 46,132 at 24.76
25.0%
Planned (10b5-1)
21 Nov 2025
Husted Amy D. Exec VP General Counsel & Sec
Sold at will
$1.12M 10,413 at 107.42
47.0%
Not planned
21 Nov 2025
Huntsman Carole Chief Commercial Officer
Sold on a plan 11×
$1.08M 1,958 at 553.11
16.3%
Planned (10b5-1)
20 Nov 2025
Karp Alexander C. See Remarks
Sold at will 19×
$58.92M 359,325 at 163.99
5.3%
Not planned
20 Nov 2025
Cohen Stephen Andrew See Remarks
Sold at will 19×
$50.61M 308,635 at 163.99
99.8%
Sold half or more
20 Nov 2025
Sankar Shyam See Remarks
Sold at will 19×
$24.58M 149,872 at 163.99
18.9%
Not planned
20 Nov 2025
Zatlyn Michelle President and Board Co-Chair · indirect
Sold on a plan 13×
$6.99M 35,099 at 199.26
58.8%
Sold half or more
20 Nov 2025
BENZENO SHARON Chief Commercial Ofc Imm Med
Sold on a plan
$4.93M 297,925 at 16.54
50.1%
Sold half or more
20 Nov 2025
Nemiroff Alex General Counsel and Secretary
Sold at will 4×
$4.85M 25,130 at 193.09
54.7%
Sold half or more
20 Nov 2025
Alameddine Rima Chief Revenue Officer
Sold on a plan
$4.69M 100,000 at 46.89
18.8%
Planned (10b5-1)
20 Nov 2025
Adarkar Prabir PRESIDENT AND COO
Sold at will 2×
$3.13M 15,960 at 196.04
1.8%
Not planned
20 Nov 2025
Taylor Ryan D. See Remarks
Sold on a plan 19×
$2.91M 17,761 at 163.99
5.8%
Planned (10b5-1)
20 Nov 2025
Hattersley Gary CHIEF SCIENTIFIC OFFICER
Sold at will 2×
$2.67M 369,051 at 7.23
100%
Sold half or more
20 Nov 2025
Mastrocola Lauren Principal Accounting Officer
Sold at will 2×
$2.61M 13,600 at 192.08
56.6%
Sold half or more
20 Nov 2025
Glazer David A. See Remarks
Sold at will 19×
$2.55M 15,557 at 163.99
3.6%
Not planned
20 Nov 2025
Kaufman Matthew D Chief Safety Officer
Sold on a plan 6×
$2.01M 20,867 at 96.10
8.0%
Planned (10b5-1)
20 Nov 2025
Chakravarthy Arvind Chief People & Systems Officer
Sold at will 5×
$1.99M 20,912 at 95.23
10.4%
Not planned
20 Nov 2025
Sammann Derek Sr MD Gl Hd Commodities Mkts · indirect
Sold at will 2×
$1.98M 7,200 at 275.67
50.6%
Sold half or more
Showing 4,151–4,200 of 4,650. ← Newer Page 84 of 93 Older →